SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001585364-24-000089
Filing Date
2024-05-16
Accepted
2024-05-16 19:28:21
Documents
3
Period of Report
2024-05-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1715902083.html 4  
1 FORM 4 wk-form4_1715902083.xml 4 8875
2 EX-24 donalpoa.htm EX-24 3373
3 GRAPHIC donalpoa001.jpg GRAPHIC 224530
  Complete submission text file 0001585364-24-000089.txt   323141
Mailing Address 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address THE SHARP BUILDING HOGAN PLACE DUBLIN 2 L2 D02 TY74 269-673-8451
PERRIGO Co plc (Issuer) CIK: 0001585364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PERRIGO COMPANY PLC 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address
O'Connor Donal (Reporting) CIK: 0001625377 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36353 | Film No.: 24957351